Operating CF
$287.95M
Capex
−$36.87M
Free Cash Flow
$251.09M
FCF Margin
+87.2%
Cash flow waterfall for Teladoc Health (TDOC) — TTM through Q1 2026
Free cash flow: $251.09M
Note: Other Investing is large — driven mainly by purchases or sales of investments.
Cash flow breakdown for Teladoc Health (TDOC) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $287.95M | $287.95M |
| Capital Expenditure | −$36.87M | $251.09M |
| Free Cash Flow | $251.09M | $251.09M |
| Acquisitions | −$17.30M | $233.79M |
| Other Investing | −$125.10M | $108.70M |
| Net Debt Change | −$550.63M | −$441.93M |
| Other Financing & FX | −$662.00K | −$442.59M |
| Net Cash Decrease | −$442.59M | −$442.59M |
- Operating Cash Flow$287.95M
- Capital Expenditure−$36.87M
- Free Cash Flow$251.09M
- Acquisitions−$17.30M
- Other Investing−$125.10M
- Net Debt Change−$550.63M
- Other Financing & FX−$662.00K
- Net Cash Decrease−$442.59M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement